As reported in Evolving-Science, currently blood tests are used for a range of diagnostic tests covering diabetes to kidney disease and in the future perhaps even Alzheimer’s disease. Blood is rich in informative proteins and molecules such as sugars and DNA that are in the circulatory system from tissues and organs. This article notes that abnormal versions or levels of certain molecules may be linked to specific conditions through sophisticated diagnostic science. Can the concept be applied to detecting cancer?
University of Pennsylvania researchers recently uncovered a possible way to “detect specific signs of a particular kind of lung cancer, from the analysis of blood samples. The disease, known as non-small cell lung carcinoma (NSCLC), has been found to release its tumor DNA into the blood. From there it can now be isolated and assessed in detail.”
Complete the article for more information. The investigators are on to a profound potential and TrialSite News will follow the work of Charu Aggarwal and Jeffrey C. Thompson from the University of Pennsylvania.
Charu Aggarwal, assistant professor of Hematology and Oncology
Jefferey C. Thompson, clinical medicine instructor